Hello everyone, I am new to the Seqanswers forum and NGS library preparation. I have prepared a library for WGS of 55 M.tb samples using Illumina DNA prep. All the samples were normalized so that the total DNA input is 100ng per sample and the protocol mentioned in the reference guide was followed as such. After library prep, tape station was performed for 16 samples using D1000 kit. The following are the qubit concentrations and tapestation results. It Would be helpful if anyone could help me interpret the data, whether I can proceed to pool all the samples and submit them for sequencing. The lab we will be outsourcing to will perform the sequencing in Novaseq 6000.
-
Last edited by Praveenebenezer; 08-07-2024, 09:06 PM. -
I don't see the traces from the TapeStation. Do you have those? -
Hi callahank, thanks for the reply. Traces can be found in the attached PDF tapestation_traces_0508.pdfComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment